UBS Group’s Citius Pharmaceuticals CTXR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $307K | Buy |
192,927
+125,712
| +187% | +$200K | ﹤0.01% | 5212 |
|
2025
Q1 | $100K | Buy |
67,215
+39,648
| +144% | +$59.1K | ﹤0.01% | 5781 |
|
2024
Q4 | $110K | Buy |
27,567
+26,962
| +4,457% | +$108K | ﹤0.01% | 5599 |
|
2024
Q3 | $303 | Sell |
605
-62,174
| -99% | -$31.1K | ﹤0.01% | 7791 |
|
2024
Q2 | $36.7K | Sell |
62,779
-71,834
| -53% | -$42K | ﹤0.01% | 5777 |
|
2024
Q1 | $121K | Sell |
134,613
-2,900
| -2% | -$2.6K | ﹤0.01% | 4980 |
|
2023
Q4 | $104K | Buy |
137,513
+39,489
| +40% | +$29.9K | ﹤0.01% | 4949 |
|
2023
Q3 | $67K | Buy |
98,024
+26,896
| +38% | +$18.4K | ﹤0.01% | 4975 |
|
2023
Q2 | $85.4K | Buy |
71,128
+70,762
| +19,334% | +$84.9K | ﹤0.01% | 5087 |
|
2023
Q1 | $428 | Buy |
+366
| New | +$428 | ﹤0.01% | 7939 |
|
2022
Q3 | – | Sell |
-1,132
| Closed | -$1K | – | 9273 |
|
2022
Q2 | $1K | Sell |
1,132
-23,099
| -95% | -$20.4K | ﹤0.01% | 8797 |
|
2022
Q1 | $43K | Sell |
24,231
-73,461
| -75% | -$130K | ﹤0.01% | 5612 |
|
2021
Q4 | $150K | Buy |
97,692
+40,930
| +72% | +$62.8K | ﹤0.01% | 4879 |
|
2021
Q3 | $115K | Buy |
56,762
+9,669
| +21% | +$19.6K | ﹤0.01% | 4674 |
|
2021
Q2 | $164K | Sell |
47,093
-65,900
| -58% | -$229K | ﹤0.01% | 4480 |
|
2021
Q1 | $201K | Buy |
112,993
+10,811
| +11% | +$19.2K | ﹤0.01% | 4510 |
|
2020
Q4 | $104K | Buy |
+102,182
| New | +$104K | ﹤0.01% | 4677 |
|
2020
Q3 | – | Sell |
-7,774
| Closed | -$9K | – | 7123 |
|
2020
Q2 | $9K | Buy |
+7,774
| New | +$9K | ﹤0.01% | 6213 |
|
2019
Q3 | – | Sell |
-3,647
| Closed | -$4K | – | 7018 |
|
2019
Q2 | $4K | Buy |
+3,647
| New | +$4K | ﹤0.01% | 6564 |
|
2019
Q1 | – | Sell |
-665
| Closed | -$1K | – | 6889 |
|
2018
Q4 | $1K | Buy |
+665
| New | +$1K | ﹤0.01% | 6949 |
|
2018
Q3 | – | Sell |
-2,572
| Closed | -$6K | – | 7041 |
|
2018
Q2 | $6K | Sell |
2,572
-2,973
| -54% | -$6.94K | ﹤0.01% | 6471 |
|
2018
Q1 | $17K | Buy |
5,545
+4,040
| +268% | +$12.4K | ﹤0.01% | 5626 |
|
2017
Q4 | $6K | Sell |
1,505
-384
| -20% | -$1.53K | ﹤0.01% | 6313 |
|
2017
Q3 | $6K | Buy |
+1,889
| New | +$6K | ﹤0.01% | 6216 |
|